An internal standard for the quantification of vigabatrin
Related Products
Unlabeled Version(s)
9000976Vigabatrin
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Vigabatrin-13C-d2 (hydrochloride)

Item No. 26672

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
4-aminohex-5-enoic-6-13C-6,6-d2 acid, monohydrochloride
CAS Number
2749628-08-6
Synonyms
  • γ-Vinyl GABA-13C-d2
Molecular Formula
C5[13C]H9D2NO2 • HCl
Formula Weight
168.6
Purity
≥99% deuterated forms (d1-d2)
Formulation
A solid
Solubility(Learn about Variance in Solubility)
Water: soluble
SMILES
NC(CCC(O)=O)/C=[13C]([2H])/[2H].Cl
InChi Code
InChI=1S/C6H11NO2.ClH/c1-2-5(7)3-4-6(8)9;/h2,5H,1,3-4,7H2,(H,8,9);1H/i1+1D2;
InChi Key
FBNKOYLPAMUOHS-YSJJXQNZSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    500 µg

    $169

    Add

    1 mg

    $303

    Add
    Product Description

    Vigabatrin-13C-d2 is intended for use as an internal standard for the quantification of vigabatrin (Item No. 9000976) by GC- or LC-MS. Vigabatrin is an irreversible GABA transaminase (GABA-T) inhibitor.1 It inhibits rat brain GABA-T when used at a concentration of 0.1 mM. Vigabatrin is selective for rat brain GABA-T over P. fluorescens GABA-T at 10 mM and is 100-fold selective over glutamic acid decarboxylase (GAD). Vigabatrin (1,500 mg/kg) decreases brain GABA-T activity without affecting GAD activity in mice.2 It reduces the incidence of myoclonus in a mouse model of audiogenic seizures.3 Vigabatrin also increases the electroconvulsive threshold in mouse model of maximal electroshock-induced seizures and reduces the number of clonic convulsions induced by pentylenetetrazol (PTZ; Item No. 18682) in mice.4 Formulations containing vigabatrin have been used in the treatment of seizures and infantile spasms.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Lippert, B., Metcalf, B.W., Jung, M.J., et al. 4-Amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. Eur. J. Biochem. 74(3), 441-445 (1977).

    2. Jung, M.J., Lippert, B., Metcalf, B.W., et al. g-Vinyl GABA (4-amino-hex-5-enoic acid), A new selective irreversible inhibitor of GABA-T: Effects on brain GABA metabolism in mice. J. Neurochem. 29(5), 797-802 (1977).

    3. Meldrum, B.S., and Murugaiah, K. Anticonvulsant action in mice with sound-induced seizures of the optical isomers of g-vinyl GABA. Eur. J. Pharm. 89(1-2), 149-152 (1983).

    4. Luszczki, J.J., and Czuczwar, S.J. Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy. Prog. Neuropsychopharmacol. Biol. Psychiatry 31(2), 529-538 (2007).